Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Omnicell to Release Second Quarter 2013 Earnings Results on August 1

OMCL
Omnicell to Release Second Quarter 2013 Earnings Results on August 1

MOUNTAIN VIEW, Calif., July 25, 2013 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, will hold a conference call Thursday, August 1, to discuss the Company's Second Quarter 2013 financial results. 

What: 

Omnicell Second Quarter 2013 earnings conference call and webcast

When: 

August 1, 2013, 1:30 p.m. PT

Who:   

Randall Lipps, chairman, president and chief executive officer


Rob Seim, chief financial officer

Where:

The conference call can be monitored by dialing 1-800-696-5518 within the U.S. or 1-706-758-4883 for all other locations. The Conference ID # is 19881764. The webcast can be accessed at: http://ir.omnicell.com/events.cfm.

How:  

Link to the Omnicell website 15 minutes prior to the call to download necessary audio software.

Replay:

Available starting at 4:30 p.m. PT on August 1, 2013 through 12:00 p.m. PT on            


August 15, 2013. Dial 1-855-859-2056 within the U.S. and 1-404-537-3406 for all other locations, Conference ID # 19881764.

(Logo:  http://photos.prnewswire.com/prnh/20120731/SF48971LOGO-a)

About Omnicell

Since 1992, Omnicell (NASDAQ: OMCL) has been creating new efficiencies to improve patient care, anywhere it is delivered. Omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire healthcare continuum— from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home.

More than 2,600 Acute Care customers worldwide have utilized Omnicell's medication automation, supply chain and analytics solutions to increase operational efficiency, reduce errors, deliver actionable intelligence and improve patient safety. Omnicell Non-Acute Care solutions, including its MTS Medication Technologies brand, provide innovative medication adherence packaging solutions to help reduce costly hospital readmissions. In addition, these solutions enable approximately 6,000 institutional and retail pharmacies worldwide to maintain high accuracy and quality standards in medication dispensing and administration while optimizing productivity and controlling costs.

OMCL-E

SOURCE Omnicell, Inc.



USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse